Guaifenesin + Pseudoephedrine - NDC Database
0363-0077 Aug 01, 2017
Guaifenesin and Pseudoephedrine Hydrochloride Oral Tablet, Extended Release by Walgreen Company
Guaifenesin and Pseudoephedrine Hydrochloride Oral Tablet, Extended Release by Walgreen Company
0363-0134 Aug 05, 2020
Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Walgreen Co.
Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Walgreen Co.
0363-0547 Jan 26, 2007
Guaifenesin 400 mg / Pseudoephedrine Hydrochloride 40 mg Oral Tablet by Walgreen Co.
Guaifenesin 400 mg / Pseudoephedrine Hydrochloride 40 mg Oral Tablet by Walgreen Co.
0363-9946 May 07, 2022
Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Walgreen Co.
Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Walgreen Co.
11584-1080 Dec 02, 2011
Despec Tablet (Guaifenesin 400 mg / Pseudoephedrine Hydrochloride 40 mg) Oral Tablet by International Ethical Labs
Despec Tablet (Guaifenesin 400 mg / Pseudoephedrine Hydrochloride 40 mg) Oral Tablet by International Ethical Labs
11822-0046 Feb 01, 2022
Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Rite Aid Corporation
Guaifenesin and Pseudoephedrine Hcl Oral Tablet, Extended Release by Rite Aid Corporation
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.